2018 Global Vibrio Testing Market: US, Europe, Japan--Sales Segment Forecasts by Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

The report presents a detailed analysis of the Vibrio diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Vibrio definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:

     - Hospitals
     - Commercial/Private Labs
     - Physician Offices
     - Public Health Labs

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.

Contains 200 pages and 7 tables

I. Introduction
II. Worldwide Test Overview,
Technologies and Instrumentation
A. Background, Diagnostic Tests, Vaccines and Drugs

B. Instrumentation Review: Operating Characteristics,
Features and Selling Princes of Leading Infectious Disease
Automated and Semi-automated Analyzers
C. Emerging Infectious Disease Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Others
D. Personal Testing
III. Country Analyses: Sales and Volume Forecasts
IV. Major Product Development Opportunities

A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
V. Design Criteria for Decentralized Testing Products
VI. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets

VII. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VIII. Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix/Erba
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher/Life Technology
- Wallac/PE
- Wako

Global Cystic Fibrosis Therapeutics Market Size study, by Class (Pancreatic Enzyme Supplements, Mucolytic, Bronchodilators, CFTR Modulators), by Route of administration (Oral Drugs, Inhaled Drugs) and Regional Forecasts 2018-2025

Global Cystic Fibrosis Therapeutics Market to reach USD XX billion by 2025.Global Cystic Fibrosis Therapeutics Market valued approximately USD XX billion in 2017 is anticipated to grow with a healthy

USD 3950 View Report

Global Smart weight, body composition & BMI scale Market Size study, by Type (Wi-Fi, Bluetooth), by Application (Household, Gym, Others) and Regional Forecasts 2018-2025

Global Smart weight, body composition & BMI scale Market to reach USD 335.71 million by 2025.Global Smart weight, body composition & BMI scale Market valued approximately USD 193.5 billion in

USD 3950 View Report

Q2 2018 Global Refinery Maintenance Review - Americas Incur the Highest Maintenance in the Quarter

Q2 2018 Global Refinery Maintenance Review - Americas Incur the Highest Maintenance in the QuarterAmong regions, North America had the highest refining capacity under maintenance (both planned and unplanned) with

USD 1500 View Report

H2 2018 Global Capacity and Capital Expenditure Outlook for Refineries - Asia and Africa Continue to Dominate Global Refinery Capex and Capacity Additions

H2 2018 Global Capacity and Capital Expenditure Outlook for Refineries - Asia and Africa Continue to Dominate Global Refinery Capex and Capacity AdditionsThe global refinery industry is expected to witness

USD 3000 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available